MONDAY, April 3, 2023 (HealthDay News) — An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says. Ficlatuzumab used in combination with the already approved targeted drug cetuximab (Erbitux) significantly improvedContinue Reading

MONDAY, April 3, 2023 (HealthDay News) – After six weeks of in-patient treatment at Walter Reed National MIlitary Medical Center, Sen. John Fetterman is back home in western Pennsylvania and in remission from depression. Fetterman will return to the Senate when Congress reconvenes April 17 after a recess. The PennsylvaniaContinue Reading

FRIDAY, March 31, 2023 (HealthDay News) — Prescriptions for attention deficit hyperactivity disorder (ADHD) medications spiked during the COVID-19 pandemic, a new government report shows. The trend may reflect both greater awareness among adults of ADHD symptoms and increased stress driving people to get the care they need. “This reportContinue Reading